• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FLEXTOME CUTTING BALLOON; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FLEXTOME CUTTING BALLOON; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 3824
Device Problems Material Rupture (1546); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation of Vessels (2135); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/25/2021
Event Type  Injury  
Event Description
It was reported that balloon burst occurred and the patient's vessel ruptured.The 90% stenosed target lesion was located in the moderately tortuous and severely calcified left main (lm) bifurcation lesion.A 15/3.75 flextome cutting balloon was selected for use.During the procedure, the balloon was advanced and slowly inflated.However, the image showed a contrast leakage.The device was removed with the guide catheter and pre-dilation balloon but was noted that it had burst.The physician rechecked by angiography and found that the patient's vessel was ruptured.The physician used a surrogate membrane stent to address the ruptured vessel and completed the procedure with a different device.No further patient complications were reported and patient was stable.
 
Manufacturer Narrative
Corrected b5 describe event or problem: the first report was submitted in error.Additional information received indicated that this report is a duplicate report.All event details have been submitted under tw# (b)(4).
 
Event Description
It was reported that balloon burst occurred and the patient's vessel ruptured.The 90% stenosed target lesion was located in the moderately tortuous and severely calcified left main (lm) bifurcation lesion.A 15/3.75 flextome cutting balloon was selected for use.During the procedure, the balloon was advanced and slowly inflated.However, the image showed a contrast leakage.The device was removed with the guide catheter and pre-dilation balloon but was noted that it had burst.The physician rechecked by angiography and found that the patient's vessel was ruptured.The physician used a surrogate membrane stent to address the ruptured vessel and completed the procedure with a different device.No further patient complications were reported and patient was stable.However, the first report was submitted in error.Additional information received indicated that this report is a duplicate report.All event details have been submitted under tw# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXTOME CUTTING BALLOON
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13374584
MDR Text Key286498048
Report Number2134265-2022-00769
Device Sequence Number1
Product Code NWX
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/25/2023
Device Model Number3824
Device Catalogue Number3824
Device Lot Number0025266766
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/09/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/20/2022
Initial Date FDA Received01/27/2022
Supplement Dates Manufacturer Received01/29/2022
Supplement Dates FDA Received02/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/26/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age58 YR
Patient SexMale
Patient Weight69 KG
-
-